查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球药用级氯化钠市场按等级、应用和地区划分－预测至2030年
市场调查报告书
商品编码
1883071

全球药用级氯化钠市场按等级、应用和地区划分－预测至2030年

Pharmaceutical-Grade Sodium Chloride Market by Grade (API-NaCl, HD-NaCl), Application (Injectables /Intravenous Solutions, Dialysis, Oral Rehydration Salts, Hemofiltration Solutions, Mechanical Cleansing Solutions), and Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 253 Pages | 订单完成后即时交付

价格

2025年全球药用级氯化钠市场规模估计为5.9亿美元，预计到2030年将达到7.7亿美元，2025年至2030年的复合年增长率为5.6%。

随着慢性肾臟病(CKD)、糖尿病和脱水等慢性疾病的盛行率持续上升，由于对静脉输液、注射和透析液的需求不断增加，预计药用级氯化钠市场将会扩张。

调查范围
调查期 2023-2030
基准年 2024
预测期 2025-2030
单元 金额（百万/十亿美元），数量（千吨）
部分 等级、用途、区域
目标区域 北美洲、亚太地区、欧洲、中东和非洲、南美洲

包括新兴经济体在内的药品和生物製药产量不断增长，也推动了对符合药典标准的高纯度氯化钠的需求。此外，基础设施投资、政府在重症监护方面的支出以及供应链设施的加强，也促进了市场成长。

药用级氯化钠市场-IMG1

“预计2025年至2030年间，HD-NaCl细分市场将呈现最高的复合年增长率。”

受医院重症治疗方法和补液疗法需求不断增长的推动，高密度氯化钠（HD-NaCl）预计将在预测期内成为医药级氯化钠市场中复合年增长率最高的产品。高密度氯化钠的消费量正在上升。由于其成本更低且可大规模生产，它正逐渐成为大规模製药和临床应用中优于原料药氯化钠的选择。

“预计到 2030 年，透析领域将占据最大的市场份额。”

药用级氯化钠市场最大的应用领域是透析，这主要受人口老化、糖尿病和高血压导致的慢性肾臟病（CKD）盛行率快速上升的推动。全球透析中心数量的增加以及家庭透析治疗机的普及进一步推动了市场需求。血液透析机和腹膜透析是两种需要持续使用大量药用级氯化钠来配製透析液的透析方法。

“预计亚太地区药用级氯化钠市场在预测期内将以最高的复合年增长率增长。”

亚太地区医药级氯化钠市场正快速成长，这主要得益于医药和生物製药生产产业的蓬勃发展，以及医院和透析基础设施投资的不断增加。有利的政府政策和低廉的生产成本抑制了具有竞争力的进口医药级氯化钠的生产。印度、中国和东南亚地区现代医学的日益普及也加速了市场的发展。

本报告分析了全球药用级氯化钠市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章 引言

第二章执行摘要

第三章 主要发现

  • 医药级氯化钠市场蕴藏着巨大的机会
  • 按等级和地区分類的药用级氯化钠市场
  • 依产品形式分類的药用级氯化钠市场
  • 按应用领域分類的医药级氯化钠市场
  • 各国药用级氯化钠市场

第四章 市场概览

  • 介绍
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 任务
  • 未满足的需求和閒置频段
    • 医药级氯化钠市场未满足的需求
    • 閒置频段机会
  • 相互关联的市场与跨产业机会
    • 互联市场
    • 跨职能机会
  • 一级/二级/三级公司的策略性倡议

第五章 产业趋势

  • 波特五力分析
  • 宏观经济分析
    • 介绍
    • GDP趋势与预测
    • 都市化和人口变化
    • 贸易与全球供应链动态
  • 价值链分析
    • 原物料采购
    • 加工、提炼和品质保证
    • 分销、物流和供应链管理
    • 转化为最终用途药品
  • 生态系分析
  • 定价分析
    • 主要企业平均售价趋势：依等级划分
    • 各地区平均销售价格趋势
  • 贸易分析
    • 导入场景
    • 出口方案
  • 重大会议和活动（2025-2026）
  • 影响客户业务的趋势/颠覆性因素
  • 案例研究分析
  • 2025年美国关税对药用级氯化钠市场的影响
    • 介绍
    • 主要关税税率
    • 价格影响分析
    • 对不同地区的主要影响
    • 对使用的影响

第六章：科技、专利、数位化和人工智慧应用带来的策略颠覆

  • 主要技术
    • 真空盐生产
    • 机械蒸气压缩（MVR）和多效蒸发（MEE）
    • 重结晶
    • 冷盐水浸出和化学沉淀
  • 互补技术
    • 粒度控制、筛分、造粒
    • 干燥技术（热风干燥、流体化床干燥）
    • PAT 和流程自动化（SCADA、DCS、在线连续品质监控）
  • 邻近技术
    • 无菌静脉输液、透析及口服补液盐生产系统
    • 洁净室、暖通空调、GMP包装技术
  • 技术/产品蓝图
    • 短期（2025-2027 年）|数位转型与生产最佳化阶段
    • 中期目标（2027-2030年）：永续生产与供应链整合
    • 长期规划（2030-2035年及以后）：生物製程整合与现场製药盐水系统
  • 专利分析
    • 介绍
    • 方法
    • 主要申请人
  • 未来应用
  • 人工智慧/生成式人工智慧对药用级氯化钠市场的影响
    • 主要应用案例和市场潜力
    • 相互关联的相邻生态系及其对市场参与者的影响
    • 医药级氯化钠市场客户对采用生成式人工智慧的准备情况
  • 成功案例和实际应用

第七章永续性与监管环境

  • 地方法规和合规性
    • 监管机构、政府机构和其他组织
    • 业界标准
  • 对永续性的承诺
  • 认证、标籤和环境标准

第八章：顾客状况与购买行为

  • 决策流程
  • 买方相关利益者和采购评估标准
    • 采购过程中的关键相关利益者
    • 采购标准
  • 招募障碍和内部挑战
  • 各种应用中未满足的需求
  • 市场盈利
    • 潜在收入
    • 成本动态
    • 利润机会：按申请

9. 药用级氯化钠市场（依等级划分）

  • 介绍
  • HD-NACL
  • API-NACL

10. 药用级氯化钠市场依产品形式划分

  • 介绍
  • 液体
  • 固体的

第十一章 药用级氯化钠市场依应用领域划分

  • 介绍
  • 透析
  • 注射
  • 口服补液盐
  • 过滤
  • 机器清洗液
  • 其他用途

12. 各地区医药级氯化钠市场

  • 介绍
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 荷兰
    • 爱尔兰
    • 土耳其
    • 俄罗斯
    • 其他欧洲
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

第十三章 竞争格局

  • 概述
  • 主要参与企业的策略
  • 收入分析
  • 市占率分析
  • 公司估值和财务指标
  • 品牌/产品对比
  • 企业评估矩阵：主要企业（2024）
  • 公司评估矩阵：Start-Ups/中小企业（2024 年）
  • 竞争场景

第十四章：公司简介

  • 主要企业
    • K+S AKTIENGESELLSCHAFT
    • SUDWESTDEUTSCHE SALZWERKE AG
    • DOMINION SALT
    • MORTON SALT, INC.
    • SALINEN AUSTRIA AG
    • MERCK KGAA
    • GROUPE SALINS
    • HUB SALT
    • JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.
    • US SALT
  • 其他公司
    • NANDU CHEMICALS
    • MACCO ORGANIQUES, SRO
    • JJ CHEMICALS
    • SALT MINERALS GMBH
    • HITECH MINERALS AND CHEMICALS GROUP
    • TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD.
    • MARKHOR SALT CO.
    • ABHAY AQUA CHEM
    • HAWKINS
    • RCI LABSCAN LIMITED
    • GLENTHAM LIFE SCIENCES LIMITED
    • FENGCHEN GROUP CO., LTD
    • DHANRAJ SUGAR PVT. LTD.
    • SD FINE-CHEM LTD
    • VM CHEMICALS

第十五章调查方法

第十六章附录

Product Code: CH 3339

The pharmaceutical-grade sodium chloride market size is estimated to be USD 0.59 billion in 2025 and is projected to reach USD 0.77 billion by 2030, at a CAGR of 5.6% from 2025 to 2030. The pharmaceutical-grade sodium chloride market will expand owing to the rise in the demand for intravenous fluids, the injectable formulations, and dialysis solutions as the prevalence of chronic diseases like chronic kidney disease (CKD), diabetes, and dehydration disorders continues to rise.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million/Billion) and Volume (Kiloton)
SegmentsGrade, Application, and Region
Regions coveredNorth America, Asia Pacific, Europe, the Middle East & Africa, and South America

The increased production of pharmaceuticals and biologics, including in the emerging economies, is also contributing to the demand for high-purity sodium chloride that is pharmacopeially acceptable. Investment in infrastructure facilities, government expenditure on critical care, and enhancements to supply chain facilities are also driving the market's growth.

Pharmaceutical-Grade Sodium Chloride Market - IMG1

"HD-NaCl segment is projected to exhibit the highest CAGR from 2025 to 2030"

The HD-NaCl is expected to record the highest CAGR in the pharmaceutical-grade sodium chloride market during the forecast period, owing to the rising demand for critical care therapies and hydration therapies provided in hospitals. Consumption of HD sodium chloride is on the rise. It is cheaper and can be produced in large quantities, making it the preferred choice over API sodium chloride for large-scale pharmaceutical and clinical usage.

"Dialysis segment is projected to capture the largest market share in 2030"

The largest application in the pharmaceutical-grade sodium chloride market is dialysis due to the rapidly rising incidences of CKD associated with older people, diabetes, and hypertension. The growth of dialysis facilities and the introduction of home dialysis units worldwide only escalates the market demand. The dialytic modalities of hemodialysis and peritoneal dialysis necessitate constant and high-volume utilization of pharmaceutical-grade sodium chloride to formulate the dialysates.

"Asia Pacific pharmaceutical-grade sodium chloride market is projected to grow at the highest CAGR during the forecast period"

The Asia Pacific is experiencing high growth in the pharmaceutical-grade sodium chloride market due to the rapid development of the pharmaceutical and biologics production industry, as well as increased investment in hospital and dialysis infrastructure. Favorable government policies and low cost of production deter competitive imported pharmaceutical-grade sodium chloride production. The increased use of modern healthcare in India, China, and Southeast Asia is reinforcing market acceleration.

By Company Type: Tier 1 - 25%, Tier 2 - 42%, and Tier 3 - 33%

By Designation: C-level Executives - 20%, Directors - 30%, and Others - 50%

By Region: North America - 20%, Europe - 10%, Asia Pacific - 40%, South America - 10%, and Middle East & Africa - 20%

Notes: Other designations include sales, marketing, and product managers.

Tier 1: >USD 1 Billion; Tier 2: USD 500 million-1 Billion; and Tier 3: <USD 500 million

Companies Covered: K+S Aktiengesellschaft (Germany), Sudwestdeutsche Salzwerke AG (Germany), Dominion Salt (New Zealand), Morton Salt, Inc. (US), and Salinen Austria AG (Austria), among other companies, are covered in the report.

The study includes an in-depth competitive analysis of these key players in the pharmaceutical-grade sodium chloride market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the pharmaceutical-grade sodium chloride market based on grade (API-NaCl and HD-NaCl), application (injectables/intravenous solutions, dialysis, oral rehydration salts, hemofiltration solutions, mechanical cleansing solutions, and other applications), and region (Asia Pacific, North America, Europe, South America, and the Middle East & Africa). The report's scope covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as partnerships, expansions, and acquisitions, associated with the market. This report also covers a competitive analysis of upcoming startups in the pharmaceutical-grade sodium chloride market ecosystem.

Reasons to Buy the Report

The report will provide market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall pharmaceutical-grade sodium chloride market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into positioning their businesses more effectively, and develop suitable go-to-market strategies. The report will help stakeholders understand the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

Analysis of key drivers (Rising dialysis treatments), restraints (Complex regulatory approvals), opportunities (Rising healthcare investment in developing regions), and challenges (Audits and documentation burdens)

  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the pharmaceutical-grade sodium chloride market
  • Market Development: Comprehensive information about profitable markets-the report analyzes the pharmaceutical-grade sodium chloride market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmaceutical-grade sodium chloride market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as K+S Aktiengesellschaft (Germany), Sudwestdeutsche Salzwerke AG (Germany), Dominion Salt (New Zealand), Morton Salt, Inc. (US), Salinen Austria AG (Austria)

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNIT CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF STRATEGIC CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: ASIA PACIFIC MARKET SIZE AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
  • 3.2 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE AND REGION
  • 3.3 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM
  • 3.4 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION
  • 3.5 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising dialysis treatments
      • 4.2.1.2 Strong demand for pharmaceutical-grade sodium chloride in North America and Europe
      • 4.2.1.3 Emerging markets driving healthcare expansion and increasing demand
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Complex regulatory approvals
      • 4.2.2.2 Dependence on stable supply of raw salt
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Rising healthcare investment in developing regions
      • 4.2.3.2 Partnerships with hospitals and pharmaceutical companies
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Strict audits and documentation burdens
      • 4.2.4.2 Competition from local low-cost producers
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
      • 4.3.1.1 Need for higher purity and specialized grades
      • 4.3.1.2 Digitalization and supply chain transparency
      • 4.3.1.3 Enhanced technical support and quality services
      • 4.3.1.4 Flexible and long-term supply models
      • 4.3.1.5 Skilled quality teams and regulatory assurance
    • 4.3.2 WHITE SPACE OPPORTUNITIES
      • 4.3.2.1 Expansion into emerging and underserved markets
      • 4.3.2.2 Development of specialty and high-performance grades
      • 4.3.2.3 Digital quality systems and traceability platforms
      • 4.3.2.4 Enhanced technical services and regulatory support
      • 4.3.2.5 Integrated supply and capacity-reliability solutions
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES' ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC ANALYSIS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECASTS
    • 5.2.3 URBANIZATION AND DEMOGRAPHIC SHIFTS
    • 5.2.4 TRADE AND GLOBAL SUPPLY CHAIN DYNAMICS
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RAW MATERIAL PROCUREMENT AND ACQUISITION
    • 5.3.2 PROCESSING, REFINING, AND QUALITY ASSURANCE
    • 5.3.3 DISTRIBUTION, LOGISTICS, AND SUPPLY CHAIN MANAGEMENT
    • 5.3.4 CONVERSION TO END-USE PHARMACEUTICAL PRODUCTS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY GRADE
    • 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT SCENARIO
    • 5.6.2 EXPORT SCENARIO
  • 5.7 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 EFFICIENT PRODUCTION OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE FROM ROCK SALT AT ENASEL, ALGERIA
    • 5.9.2 TRANSFORMING LOW-QUALITY SOLAR SALT INTO PHARMACEUTICAL-GRADE SODIUM CHLORIDE IN BANGLADESH
  • 5.10 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
    • 5.10.3 PRICE IMPACT ANALYSIS
    • 5.10.4 KEY IMPACT ON VARIOUS REGIONS
    • 5.10.5 IMPACT ON APPLICATIONS

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

  • 6.1 KEY TECHNOLOGIES
    • 6.1.1 VACUUM SALT PRODUCTION
    • 6.1.2 MECHANICAL VAPOR RECOMPRESSION (MVR) & MULTIPLE-EFFECT EVAPORATION (MEE)
    • 6.1.3 RECRYSTALLIZATION
    • 6.1.4 COLD BRINE LEACHING & CHEMICAL PRECIPITATION
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 PARTICLE SIZE CONTROL, SIEVING, AND GRANULATION
    • 6.2.2 DRYING TECHNOLOGY (HOT AIR & FLUID BED DRYING)
    • 6.2.3 PAT & PROCESS AUTOMATION (SCADA, DCS, INLINE QUALITY MONITORING)
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 STERILE INTRAVENOUS FLUID, DIALYSIS, AND ORS PRODUCTION SYSTEMS
    • 6.3.2 CLEANROOM, HVAC, AND GMP PACKAGING TECHNOLOGIES
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
    • 6.4.1 SHORT-TERM (2025-2027) | DIGITAL TRANSITION AND PRODUCTION OPTIMIZATION PHASE
    • 6.4.2 MID-TERM (2027-2030): SUSTAINABLE PRODUCTION & SUPPLY CHAIN INTEGRATION
    • 6.4.3 LONG-TERM (2030-2035+): BIOPROCESS INTEGRATION & ON-SITE PHARMACEUTICAL BRINE SYSTEMS
  • 6.5 PATENT ANALYSIS
    • 6.5.1 INTRODUCTION
    • 6.5.2 APPROACH
    • 6.5.3 TOP APPLICANTS
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 ADVANCED APPLICATIONS IN INJECTABLES, DIALYSIS, AND BIOPROCESSING SYSTEMS
  • 6.7 IMPACT OF AI/GEN AI ON PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
    • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.7.3 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
  • 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
    • 6.8.1 K+S AKTIENGESELLSCHAFT ENABLES CRITICAL PHARMACEUTICAL SUPPLY SUPPORT DURING GLOBAL COVID-19 VACCINATION ROLLOUT

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE
      • 7.2.1.1 Carbon Impact Reduction
      • 7.2.1.2 Eco-Applications
  • 7.3 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS APPLICATIONS
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION

9 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE

  • 9.1 INTRODUCTION
  • 9.2 HD-NACL
    • 9.2.1 UNMATCHED STABILITY, HEIGHT, AND LIFTING POWER TO DRIVE DEMAND
  • 9.3 API-NACL
    • 9.3.1 HIGH REGULATORY COMPLIANCE, PURITY ASSURANCE, AND FUNCTIONAL PERFORMANCE TO AUGMENT DEMAND

10 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM

  • 10.1 INTRODUCTION
  • 10.2 LIQUID
    • 10.2.1 GROWING DEMAND FOR ORAL ELECTROLYTE THERAPIES TO DRIVE DEMAND
  • 10.3 SOLID
    • 10.3.1 RISING GLOBAL HOSPITALIZATION RATES TO AUGMENT DEMAND

11 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
  • 11.2 DIALYSIS
    • 11.2.1 GROWING DIALYSIS PATIENT POPULATION TO FUEL MARKET GROWTH
  • 11.3 INJECTABLES
    • 11.3.1 GROWING USE OF IV THERAPIES AND SURGICAL PROCEDURES TO DRIVE DEMAND
  • 11.4 ORAL REHYDRATION SALTS
    • 11.4.1 GROWING GLOBAL NEED FOR EFFECTIVE DEHYDRATION MANAGEMENT TO DRIVE DEMAND
  • 11.5 HEMOFILTRATION SOLUTIONS
    • 11.5.1 ADVANCED RENAL REPLACEMENT REQUIREMENTS TO ACCELERATE DEMAND
  • 11.6 MECHANICAL CLEANING SOLUTIONS
    • 11.6.1 INCREASING SURGICAL ACTIVITIES AND HOSPITAL HYGIENE STANDARDS TO DRIVE DEMAND
  • 11.7 OTHER APPLICATIONS

12 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 ASIA PACIFIC
    • 12.2.1 CHINA
      • 12.2.1.1 Pharmaceutical industry and shift toward advanced drug development to drive market
    • 12.2.2 JAPAN
      • 12.2.2.1 Accelerating aging population and rising healthcare demand to drive market
    • 12.2.3 INDIA
      • 12.2.3.1 Growing generic injectable drug industry to drive market
    • 12.2.4 SOUTH KOREA
      • 12.2.4.1 Rapidly aging population and rising healthcare demand to propel market
    • 12.2.5 REST OF ASIA PACIFIC
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Rising renal replacement therapy demand to boost consumption
    • 12.3.2 FRANCE
      • 12.3.2.1 Growing adoption of home hemodialysis
    • 12.3.3 UK
      • 12.3.3.1 CKD prevalence and aging population to accelerate market
    • 12.3.4 ITALY
      • 12.3.4.1 Expanding healthcare infrastructure to drive demand
    • 12.3.5 SPAIN
      • 12.3.5.1 Strong organ donation infrastructure and rising dialysis volume to accelerate market growth
    • 12.3.6 NETHERLANDS
      • 12.3.6.1 Increasing CKD incidence and elderly population expansion to support market growth
    • 12.3.7 IRELAND
      • 12.3.7.1 Increasing incidence of kidney failure and expanding renal care needs to boost market
    • 12.3.8 TURKEY
      • 12.3.8.1 High incidence of end-stage kidney disease to boost market
    • 12.3.9 RUSSIA
      • 12.3.9.1 Expanding dialysis centers and rising CKD burden to propel market
    • 12.3.10 REST OF EUROPE
  • 12.4 NORTH AMERICA
    • 12.4.1 US
      • 12.4.1.1 Aging population increasing hospital and infusion needs to boost market
    • 12.4.2 CANADA
      • 12.4.2.1 Rising CKD and expanding dialysis needs to boost market
    • 12.4.3 MEXICO
      • 12.4.3.1 Rapidly aging population to propel the market
  • 12.5 SOUTH AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Rising CKD burden and rapid population aging fueling the demand
    • 12.5.2 ARGENTINA
      • 12.5.2.1 Healthcare modernization and rising chronic disease burden to augment market
    • 12.5.3 REST OF SOUTH AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GCC COUNTRIES
      • 12.6.1.1 Saudi Arabia
        • 12.6.1.1.1 High CKD and diabetes burden paired with Vision 2030 healthcare expansion to drive market
      • 12.6.1.2 UAE
        • 12.6.1.2.1 High diabetes and CKD burden to boost market
      • 12.6.1.3 Rest of GCC countries
    • 12.6.2 SOUTH AFRICA
      • 12.6.2.1 Expanding healthcare & dialysis infrastructure to drive market
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES
  • 13.3 REVENUE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.5.1 COMPANY VALUATION
    • 13.5.2 FINANCIAL METRICS
  • 13.6 BRAND/PRODUCT COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.7.5.1 Company footprint
      • 13.7.5.2 Region footprint
      • 13.7.5.3 Grade footprint
      • 13.7.5.4 Product form footprint
      • 13.7.5.5 Application footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 13.8.6 DETAILED LIST OF KEY STARTUPS/SMES
    • 13.8.7 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 DEALS
    • 13.9.2 EXPANSIONS
    • 13.9.3 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 K+S AKTIENGESELLSCHAFT
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Others
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 SUDWESTDEUTSCHE SALZWERKE AG
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 MnM view
        • 14.1.2.3.1 Key strengths
        • 14.1.2.3.2 Strategic choices
        • 14.1.2.3.3 Weaknesses and competitive threats
    • 14.1.3 DOMINION SALT
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 MnM view
        • 14.1.3.3.1 Key strengths
        • 14.1.3.3.2 Strategic choices
        • 14.1.3.3.3 Weaknesses and competitive threats
    • 14.1.4 MORTON SALT, INC.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Key strengths
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 SALINEN AUSTRIA AG
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 MnM view
        • 14.1.5.3.1 Key strengths
        • 14.1.5.3.2 Strategic choices
        • 14.1.5.3.3 Weaknesses and competitive threats
    • 14.1.6 MERCK KGAA
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Expansions
      • 14.1.6.4 MnM view
    • 14.1.7 GROUPE SALINS
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
      • 14.1.7.4 MnM view
    • 14.1.8 HUB SALT
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 MnM view
    • 14.1.9 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Solutions/Services offered
      • 14.1.9.3 MnM view
    • 14.1.10 US SALT
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Solutions/Services offered
      • 14.1.10.3 MnM view
  • 14.2 OTHER PLAYERS
    • 14.2.1 NANDU CHEMICALS
    • 14.2.2 MACCO ORGANIQUES, S.R.O.
    • 14.2.3 J J CHEMICALS
    • 14.2.4 SALT MINERALS GMBH
    • 14.2.5 HITECH MINERALS AND CHEMICALS GROUP
    • 14.2.6 TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD.
    • 14.2.7 MARKHOR SALT CO.
    • 14.2.8 ABHAY AQUA CHEM
    • 14.2.9 HAWKINS
    • 14.2.10 RCI LABSCAN LIMITED
    • 14.2.11 GLENTHAM LIFE SCIENCES LIMITED
    • 14.2.12 FENGCHEN GROUP CO., LTD
    • 14.2.13 DHANRAJ SUGAR PVT. LTD.
    • 14.2.14 SD FINE-CHEM LTD
    • 14.2.15 VM CHEMICALS

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH DATA
    • 15.1.1 SECONDARY DATA
      • 15.1.1.1 Key data from secondary sources
    • 15.1.2 PRIMARY DATA
      • 15.1.2.1 Key data from primary sources
      • 15.1.2.2 Key industry insights
  • 15.2 MARKET SIZE ESTIMATION
  • 15.3 BASE NUMBER CALCULATION
    • 15.3.1 DEMAND-SIDE APPROACH
    • 15.3.2 SUPPLY-SIDE APPROACH
  • 15.4 MARKET FORECAST APPROACH
    • 15.4.1 SUPPLY SIDE
    • 15.4.2 DEMAND SIDE
  • 15.5 DATA TRIANGULATION
  • 15.6 FACTOR ANALYSIS
  • 15.7 RESEARCH ASSUMPTIONS
  • 15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: IMPACT OF PORTER'S FIVE FORCES ANALYSIS
  • TABLE 2 GLOBAL GDP GROWTH PROJECTION, 2021-2028 (USD TRILLION)
  • TABLE 3 ROLE OF COMPANIES IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE ECOSYSTEM
  • TABLE 4 AVERAGE SELLING PRICE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE OFFERED BY KEY PLAYERS, BY GRADE, 2024 (USD/KG)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY REGION, 2023-2025 (USD/KG)
  • TABLE 6 IMPORT DATA FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 7 EXPORT DATA FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 8 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 9 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: LIST OF MAJOR PATENTS: 2024
  • TABLE 10 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 GLOBAL INDUSTRY STANDARDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
  • TABLE 17 CERTIFICATIONS, LABELING, ECO-STANDARDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%)
  • TABLE 19 KEY BUYING CRITERIA, BY APPLICATION
  • TABLE 20 UNMET NEEDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET IN KEY APPLICATIONS
  • TABLE 21 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 22 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTONS)
  • TABLE 23 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (USD MILLION)
  • TABLE 24 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (KILOTONS)
  • TABLE 25 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 26 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTONS)
  • TABLE 27 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 28 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION, 2023-2030 (KILOTON)
  • TABLE 29 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (KILOTON)
  • TABLE 31 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 33 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (KILOTON)
  • TABLE 35 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 37 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 38 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 39 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 40 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 41 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 42 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 43 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 44 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 45 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 46 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 47 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 48 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 49 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 50 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 51 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 52 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 53 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 54 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 55 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 56 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 57 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (KILOTON)
  • TABLE 59 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 60 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 61 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (USD MILLION)
  • TABLE 62 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (KILOTON)
  • TABLE 63 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 64 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 65 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 66 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 67 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 68 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 69 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 70 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 71 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 72 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 73 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 74 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 75 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 76 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 77 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 78 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 79 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 81 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 82 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 83 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 84 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 85 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 86 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 87 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 88 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 89 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 90 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 91 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 92 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 93 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 94 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 95 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 97 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 98 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 99 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 100 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 101 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 102 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 103 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 104 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 105 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (KILOTON)
  • TABLE 107 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 109 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (USD MILLION)
  • TABLE 110 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (KILOTON)
  • TABLE 111 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 112 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 113 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 114 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 115 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 116 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 117 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 118 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 119 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 120 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 121 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 122 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 123 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 124 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 125 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 126 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (KILOTON)
  • TABLE 127 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 128 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 129 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (USD MILLION)
  • TABLE 130 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (KILOTON)
  • TABLE 131 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 132 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 133 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 134 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 135 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 136 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 137 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 138 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 139 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 140 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 141 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 143 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 145 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023-2030 (KILOTON)
  • TABLE 147 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 149 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023-2030 (KILOTON)
  • TABLE 151 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 153 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 155 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 157 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 158 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 159 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 160 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 161 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 162 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 163 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 164 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 165 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 166 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 167 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 168 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 169 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 170 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 171 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 172 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 173 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (USD MILLION)
  • TABLE 174 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023-2030 (KILOTON)
  • TABLE 175 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 176 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023-2030 (KILOTON)
  • TABLE 177 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS BETWEEN JANUARY 2021 AND NOVEMBER 2025
  • TABLE 178 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DEGREE OF COMPETITION
  • TABLE 179 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: REGION FOOTPRINT
  • TABLE 180 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: GRADE FOOTPRINT
  • TABLE 181 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: PRODUCT FORM FOOTPRINT
  • TABLE 182 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: APPLICATION FOOTPRINT
  • TABLE 183 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 184 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 185 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DEALS, JANUARY 2021-NOVEMBER 2025
  • TABLE 186 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: EXPANSIONS, JANUARY 2021-NOVEMBER 2025
  • TABLE 187 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2025
  • TABLE 188 K+S AKTIENGESELLSCHAFT: COMPANY OVERVIEW
  • TABLE 189 K+S AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 190 K+S AKTIENGESELLSCHAFT: OTHERS
  • TABLE 191 SUDWESTDEUTSCHE SALZWERKE AG: COMPANY OVERVIEW
  • TABLE 192 SUDWESTDEUTSCHE SALZWERKE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 193 DOMINION SALT: COMPANY OVERVIEW
  • TABLE 194 DOMINION SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 195 MORTON SALT, INC.: COMPANY OVERVIEW
  • TABLE 196 MORTON SALT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 197 SALINEN AUSTRIA AG: COMPANY OVERVIEW
  • TABLE 198 SALINEN AUSTRIA AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 199 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 200 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 201 MERCK KGAA: EXPANSIONS
  • TABLE 202 GROUPE SALINS: COMPANY OVERVIEW
  • TABLE 203 GROUPE SALINS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 204 GROUPE SALINS: DEALS
  • TABLE 205 HUB SALT: COMPANY OVERVIEW
  • TABLE 206 HUB SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 207 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 208 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 209 US SALT: COMPANY OVERVIEW
  • TABLE 210 US SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 211 NANDU CHEMICALS: COMPANY OVERVIEW
  • TABLE 212 MACCO ORGANIQUES, S.R.O.: COMPANY OVERVIEW
  • TABLE 213 J J CHEMICALS: COMPANY OVERVIEW
  • TABLE 214 SALT MINERALS GMBH: COMPANY OVERVIEW
  • TABLE 215 HITECH MINERALS AND CHEMICALS GROUP: COMPANY OVERVIEW
  • TABLE 216 TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD.: COMPANY OVERVIEW
  • TABLE 217 MARKHOR SALT CO.: COMPANY OVERVIEW
  • TABLE 218 ABHAY AQUA CHEM: COMPANY OVERVIEW
  • TABLE 219 HAWKINS: COMPANY OVERVIEW
  • TABLE 220 RCI LABSCAN LIMITED: COMPANY OVERVIEW
  • TABLE 221 GLENTHAM LIFE SCIENCES LIMITED: COMPANY OVERVIEW
  • TABLE 222 FENGCHEN GROUP CO., LTD: COMPANY OVERVIEW
  • TABLE 223 DHANRAJ SUGAR PVT. LTD.: COMPANY OVERVIEW
  • TABLE 224 SD FINE-CHEM LTD: COMPANY OVERVIEW
  • TABLE 225 VM CHEMICALS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PHARMACEUTICAL-GRADE MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 GLOBAL PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, 2025-2030
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET (2021-2025)
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DURING FORECAST PERIOD
  • FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, 2024
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 8 HIGH DEMAND FOR DIALYSIS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 9 ASIA PACIFIC ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 10 LIQUID SEGMENT DOMINATED PHARMACEUTICAL-GRADE MARKET IN 2024
  • FIGURE 11 DIALYSIS SEGMENT ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET IN 2024
  • FIGURE 12 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 13 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 CHRONIC KIDNEY DISEASE RISING AS LEADING CAUSE OF DEATH WORLDWIDE
  • FIGURE 15 CHRONIC KIDNEY DISEASE PREVALENCE: EUROPE COMPARED TO GLOBAL LEVELS
  • FIGURE 16 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION (2022 VS. 2050)
  • FIGURE 17 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 18 NUMBER OF PEOPLE LIVING IN URBAN AND RURAL AREAS, WORLD (2010-2024)
  • FIGURE 19 GLOBAL TRADE IN MERCHANDISE, 2014-2024
  • FIGURE 20 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE OFFERED BY KEY PLAYERS, BY GRADE, 2024 (USD/KG)
  • FIGURE 23 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY REGION, 2023-2025 (USD/KG)
  • FIGURE 24 IMPORT SCENARIO FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 25 EXPORT SCENARIO FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 27 LIST OF MAJOR PATENTS RELATED TO PHARMACEUTICAL-GRADE SODIUM CHLORIDE, 2015-2024
  • FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR PHARMACEUTICAL-GRADE SODIUM CHLORIDE, 2015-2024
  • FIGURE 29 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DECISION-MAKING FACTORS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION
  • FIGURE 31 KEY BUYING CRITERIA, BY APPLICATION
  • FIGURE 32 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • FIGURE 33 HD-NACL SEGMENT TO DOMINATE MARKET IN 2025
  • FIGURE 34 LIQUID SEGMENT TO DOMINATE MARKET IN 2025
  • FIGURE 35 DIALYSIS SEGMENT TO DOMINATE MARKET IN 2025
  • FIGURE 36 ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DURING FORECAST PERIOD
  • FIGURE 37 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SNAPSHOT
  • FIGURE 38 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SNAPSHOT
  • FIGURE 39 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020-2024 (USD BILLION)
  • FIGURE 40 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SHARE ANALYSIS, 2024
  • FIGURE 41 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY VALUATION
  • FIGURE 42 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: FINANCIAL MATRIX (EV/EBITDA RATIO)
  • FIGURE 43 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA
  • FIGURE 44 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 45 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 46 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY FOOTPRINT
  • FIGURE 47 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 48 K+S AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
  • FIGURE 49 SUDWESTDEUTSCHE SALZWERKE AG: COMPANY SNAPSHOT
  • FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 51 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: RESEARCH DESIGN
  • FIGURE 52 BREAKDOWN OF INTERVIEWS WITH EXPERTS
  • FIGURE 53 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 54 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 55 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: APPROACH 1
  • FIGURE 56 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET
  • FIGURE 57 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DATA TRIANGULATION